Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2022-06-01 2022-06-01
Drug Identification Number 02248361 02248361
Brand name VIVAXIM VIVAXIM
Common or Proper name Combined Purified Vi Polysaccharide Typhoid and Inactivated Hepatitis A Vaccine Combined Purified Vi Polysaccharide Typhoid and Inactivated Hepatitis A Vaccine
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients HEPATITIS A VACCINE, INACTIVATED SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE HEPATITIS A VACCINE, INACTIVATED SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE
Strength(s) 160UNIT 25MCG 160UNIT 25MCG
Dosage form(s) SUSPENSION SOLUTION SUSPENSION SOLUTION SUSPENSION SOLUTION SUSPENSION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 1.0 mL (single dose) dual chamber syringe 1 x 1.0 mL (single dose) dual chamber syringe
ATC code J07CA J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-05-31 2022-05-31
Remaining supply date 2022-05-31 2022-05-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinuation of the manufacturing of this product. Discontinuation of the manufacturing of this product.
Health Canada comments